Furthermore, the IDH mutation or its produced oncometabolite stimulate chondrogenic differentiation while inhibiting the osteogenic differentiation of mesenchymal stem cells, which are the presumed cells of origin of cartilage tumours [12,13]. Here, IDH1 is linked to chondrogenic neoplasm.